You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 77 No. 3, September 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  Papers Read at the Fifteenth Annual Meeting of the Central Surgical Association, Columbus, Ohio, Feb. 20, 21, and 22, 1958
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Peptic Ulcer Associated with Tumors of the Pancreas

HARRY A. OBERHELMAN, Jr., M.D.; THOMAS S. NELSEN, M.D.; LESTER R. DRAGSTEDT, M.D., Ph.D.

AMA Arch Surg. 1958;77(3):402-415.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The association of progressive and recurrent peptic ulceration with non-insulin-producing islet-cell tumors of the pancreas was first observed by Zollinger and Ellison in 1955.1 In 19562 Ellison reviewed 24 cases of ulcerogenic tumors of the pancreatic islets from various sources and characterized this new clinical syndrome. It consisted of a hypersecretion of gastric juice with progressive peptic ulceration, recurring despite adequate medical and surgical therapy, and the presence of non-insulin-producing islet-cell tumors of the pancreas. The ulcers were frequently located in atypical sites, such as the jejunum and distal duodenum, as well as the esophagus, stomach, and duodenal bulb. Symptoms were usually referable to the ulcer and its complications and frequently resulted in death. The majority of these islet-cell tumors were considered malignant and in most instances consisted of cells devoid of beta granules, suggesting that they might be of alpha-cell origin. Since glucagon, or hyperglycemic-glycogenolytic factor, is . . . [Full Text PDF of this Article]


Author Affiliations

Chicago

From the Department of Surgery, The University of Chicago.


Footnotes

Submitted for publication March 28, 1958.

Read at the 15th Annual Assembly of the Central Surgical Association, Columbus, Ohio, Feb. 21, 1958.

This work has been aided by grants from the Otho S. A. Sprague Memorial Institute and from the Division of Research Grants and Fellowships, National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.